Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies
Saved in:
Main Authors: | Genevieve Ho, BMed/MB, MMed (Author), Matthew Gibson, MBBS, MMed, DCH (Author), Nooshafarin Kazemikhoo, MD, PhD (Author), Dedee F. Murrell, MA, BMBCh, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)Capsule Summary
by: Clare L. Rogers, BSc Med (Hons), et al.
Published: (2021) -
Prevalence of anemia in patients with epidermolysis bullosa registered in Australia
by: Shelley Ji Eun Hwang, BSc (Med), et al.
Published: (2015) -
Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosa
by: Minhee Kim, MBBS, et al.
Published: (2016) -
Assessing the quality of life in the families of patients with epidermolysis bullosa: The mothers as main caregivers
by: Fatemeh Chogani, MD, et al.
Published: (2021) -
Pretibial Epidermolysis Bullosa
by: Joshi Arun, et al.
Published: (2002)